CLEARBRIDGE HEALTH LTD
Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally. It operates through Strategic Investments, Healthcare Systems, and Medical Clinics/Centres segments. The company provides imaging services, including general x-ray, computerized tomography scan, dental cone beam CT scan, mammography, mag… Read more
Market Cap & Net Worth: CLEARBRIDGE HEALTH LTD (5C6)
CLEARBRIDGE HEALTH LTD (F:5C6) has a market capitalization of $2.20 Million (€2.15 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #35830 globally and #4298 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CLEARBRIDGE HEALTH LTD's stock price €0.00 by its total outstanding shares 4295820825 (4.30 Billion).
CLEARBRIDGE HEALTH LTD Market Cap History: 2020 to 2026
CLEARBRIDGE HEALTH LTD's market capitalization history from 2020 to 2026. Data shows change from $361.58 Million to $2.20 Million (-60.43% CAGR).
CLEARBRIDGE HEALTH LTD Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CLEARBRIDGE HEALTH LTD's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 5C6 by Market Capitalization
Companies near CLEARBRIDGE HEALTH LTD in the global market cap rankings as of March 18, 2026.
Key companies related to CLEARBRIDGE HEALTH LTD by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
CLEARBRIDGE HEALTH LTD Historical Marketcap From 2020 to 2026
Between 2020 and today, CLEARBRIDGE HEALTH LTD's market cap moved from $361.58 Million to $ 2.20 Million, with a yearly change of -60.43%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €2.20 Million | -50.00% |
| 2025 | €4.41 Million | -33.33% |
| 2024 | €6.61 Million | -85.71% |
| 2023 | €46.30 Million | -54.35% |
| 2022 | €101.42 Million | -73.86% |
| 2021 | €388.04 Million | +7.32% |
| 2020 | €361.58 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CLEARBRIDGE HEALTH LTD was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.20 Million USD |
| MoneyControl | $2.20 Million USD |
| MarketWatch | $2.20 Million USD |
| marketcap.company | $2.20 Million USD |
| Reuters | $2.20 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.